The role of convergent ion channel pathways in microglial phenotypes: a systematic review of the implications for neurological and psychiatric disorders

Abstract

Increases in the activated state of microglia, the main neuroimmune cells, are widely reported in the brains of patients with neurological and psychiatric disorders. Microglia transform from the resting to the activated state by sensing their environment, aided by a variety of ion channels. To examine the effect of ion channels on microglial phenotypes, we conducted a systematic review of immunohistochemical analyses of these neuroimmune cells in animal models following administration of ion channel antagonists, compared to control conditions. A systematic search of the PubMed and Web of Science electronic databases using the PRISMA and WHO methodologies for systematic reviews yielded 15 original peer-reviewed studies. The majority (13 out of 15) of these studies reported a decrease in microglial activated state after ion signaling pharmacological blockade. The studies provide evidence that acute administration of ion channel antagonists leads to a reduction in microglial activation in rodent brains in the models for epilepsy, Parkinson’s disease, inflammation, pain, ischemia, and brain and spinal cord injury. Future research should explore microglial-specific druggable targets for neurological and psychiatric disorders. The investigation of acute and chronic administration of ion channel antagonists in microglial phenotypes in primates and the development of microglia-like cells derived from human stem cells could be valuable sources in this direction.

More on neurotransmitters

“…Channelopathies are of particular interest in cardiology and neurology but are also notable in pain and emotional disorders. [21][22][23][24][25][26] Voltage-gated sodium channels are thought to be involved in general anesthesia. 27 Adverse effects of some psychotropic medications are best understood as ion channel dysfunction.…”

Microglia and its role in neurodegenerative diseases

“…Many studies have been conducted to understand the molecules responsible for microglial activation and the pathways that these molecules activate (Raivich et al, 1999;Hung et al, 2017;Xu et al, 2018). Microglia have been thought to play a triggering role in electrical changes caused by neuronal damage and ion changes around the damaged neurons in molecular activation in in vivo studies (Quagliato and Nardi, 2018), while some studies have indicated that activation occurs by low molecular weight active molecules (peptides, hormones, etc.) (Park and Chun, 2017;Bast et al, 2018).…”

CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus

“…In response to various stresses, microglia show hypertrophic and/or elongated morphologies with hyper-ramified processes (intermediate states) and finally amoeboid shape indicating phagocytic and cytotoxic activity (activated states) [2]. Microglial activation is mediated by various receptors and ion channels (such as purinergic receptors, C-X3-C motif chemokine receptor, transient receptor potential channel (TRPC) and K + channels), which activate diverse signaling molecules including the nuclear factor of activated T-cells, nuclear factor-κB (NFκB), mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3-kinase (PI3K)/AKT [3]. This microglial activation seems to play an important role in epileptogenic processes.…”